Morgan Stanley said investors should keep building positions in Salesforce (NYSE: CRM), arguing that its latest results show the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot List Hot List Pro

salesforce.com (CRM) PT Lowered to $300 at CFRASeptember 4, 2025 12:59 PM salesforce.com (CRM) PT Lowered to $325 at BairdSeptember 4, 2025 10:08 AM Popular stocks volume: AEO CRM AMD HPE BABA PLTR AI NIO AVGO HOOD SOFISeptember 4, 2025 10:00 AM TD Cowen Reiterates Buy Rating on salesforce.com (CRM)September 4, 2025 9:55 AM salesforce.com (CRM) PT Lowered to $250 at RBC CapitalSeptember 4, 2025 9:31 AM salesforce.com (CRM) PT Lowered to $315 at Piper SandlerSeptember 4, 2025 9:08 AM salesforce.com (CRM) PT Lowered to $340 at Deutsche BankSeptember 4, 2025 7:19 AM Oppenheimer Reiterates Outperform Rating on salesforce.com (CRM)September 4, 2025 6:32 AM salesforce.com (CRM) PT Lowered to $265 at Wells FargoSeptember 4, 2025 6:07 AM Form 10-Q Salesforce, Inc. For: Jul 31September 4, 2025 6:04 AM